EPZM - Epizyme - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $7.09. This is a potential upside of $7.09 (0%) from yesterday's end of day stock price of $0.

Epizyme's activity chart (see below) currently has 96 price targets and 83 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 57.76% with an average time for these price targets to be met of 397.92 days.

Most recent stock forecast was given by YARON WERBER from TD COWEN on 28-Jun-2022. First documented stock forecast 12-Sep-2014.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 28-Jun-2022

$1.5

$0.03 (2.04%)

3 years 9 months 6 days ago
(28-Jun-2022)

2/4 (50%)

$0.02 (1.35%)

161

Hold Since 28-Jun-2022

$1.5

$0.03 (2.04%)

$12

3 years 9 months 6 days ago
(28-Jun-2022)

1/3 (33.33%)

$0.02 (1.35%)

38

Hold Since 27-Jun-2022

$30

3 years 9 months 7 days ago
(27-Jun-2022)

2/5 (40%)

$12.54 (71.82%)

611

Buy Since 02-Mar-2022

3 years 10 months ago
(03-Jun-2022)

2/2 (100%)

$13 (108.33%)

808

Sell Since 10-Aug-2021

$5

$3.53 (240.14%)

4 years 7 months 24 days ago
(10-Aug-2021)

4/8 (50%)

$-0.5 (-9.09%)

70

Show more analysts

Please expand the browser size to see the chart

What is EPZM (Epizyme) average time for price targets to be met?

On average it took 397.92 days on average for the stock forecasts to be realized with a an average price target met ratio 57.76

Which analyst has the current highest performing score on EPZM (Epizyme) with a proven track record?

ANDREW FEIN

Which analyst has the most public recommendations on EPZM (Epizyme)?

Andrew Fein works at HC WAINWRIGHT and has 18 price targets and 21 ratings on EPZM

Which analyst is the currently most bullish on EPZM (Epizyme)?

Robyn Karnauskas with highest potential upside - $27.53

Which analyst is the currently most reserved on EPZM (Epizyme)?

David Nierengarten with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?